Erythropoietin Protects Very Preterm Infants Against Necrotizing Enterocolitis

PHASE2CompletedINTERVENTIONAL
Enrollment

1,285

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

April 30, 2019

Study Completion Date

April 30, 2019

Conditions
Premature Infant
Interventions
DRUG

EPO

Infants in EPO group are administered 500IU/kg intravenously within 72 hours after birth every other day for 2 weeks.

DRUG

Normal saline

Infants in control group are administered normal saline with the same volume and period as EPO.

Trial Locations (1)

450052

Third Affiliated Hospital of Zhengzhou University, Zhengzhou

All Listed Sponsors
collaborator

Zhengzhou Children's Hospital, China

OTHER

collaborator

The First Affiliated Hospital of Zhengzhou University

OTHER

collaborator

Women and Children Health Care Center of Luoyang, China

UNKNOWN

collaborator

Göteborg University

OTHER

lead

Zhengzhou University

OTHER

NCT03919500 - Erythropoietin Protects Very Preterm Infants Against Necrotizing Enterocolitis | Biotech Hunter | Biotech Hunter